The Neoplastic Hematopathology Update Course will be held on November 8 to 10, 2018 in The Waterfront Beach Resort, A Hilton Hotel, Huntington Beach, CA. 

Explore recent developments in the diagnosis, classification, and molecular biology of lymphoid and myeloid neoplasms and related disorders. Recognize the impact of new developments on targeted and precision therapy, and best practices for diagnosis, classification, and detection of diagnostic, prognostic, and therapeutic markers.

Objectives

At the end of this continuing medical education activity, participants should be able to:

• Describe recent developments in the diagnosis, classification and molecular biology of lymphoid and myeloid neoplasms and related disorders.
• Recognize the impact of new developments on targeted and precision therapy.
• Implement current best practices for diagnosis, classification, and detection of diagnostic, prognostic, and therapeutic markers.

Target Audience

Practicing pathologists with an interest or training in hematopathology, as well as oncologists, hematologists, and advanced trainees.

The following credit type(s) are being offered for this course:

AMA PRA Category1™ (15.75)

For more information and to register:
https://cme.cityofhope.org/eventinfo_9520.html